Table 3.
Univariate relation of LogPCSK9 to relevant variables in the total cohort, control group and ART group
| Independent variable | Overall cohort | Controls | ART | |||
|---|---|---|---|---|---|---|
| Beta | p value | Beta | p value | Beta | p value | |
| Age (years) | − 0.405 | < 0.001 | 0.227 | 0.053 | ||
| Total cholesterol (mg/dl) | 0.186 | 0.025 | 0.388 | 0.001 | ||
| LDL-C (mg/dl) | 0.180 | 0.029 | 0.312 | 0.007 | ||
| HDL-C (mg/dl) | 0.249 | 0.034 | ||||
| ApoB (mg/dl) | 0.258 | 0.027 | ||||
| Birth length (cm) | − 0.332 | 0.006 | 0.225 | 0.059 | ||
| Body mass index (kg/m2) | ||||||
| Height (cm) | − 0.430 | p < 0.001 | ||||
| Waist-to-hip ratio | 0.279 | 0.019 | ||||
| HOMA-IR | 0.252 | 0.034 | ||||
| Insulin (mU/l) | 0.262 | 0.027 | ||||
| Systolic blood pressure (mmHg) | 0.199 | 0.021 | ||||
PCSK9 proprotein convertase subtilisin/kexin type 9, ART assisted reproductive technologies, LDL-C low-density lipoprotein, HDL-C high-density lipoprotein, ApoB apolipoproteinB, HOMA-IR homeostasis model assessment of insulin resistance